Blood Sugar + Dual Receptor

MOUNJARO®

The first FDA-approved dual GIP and GLP-1 receptor agonist for type 2 diabetes. Once weekly.

  • No Insurance Required

  • Ships From USA Pharmacy

  • Free Medical Consultation

  • No Subscription Required

  • FDA-Approved

  • Licensed Provider

  • Licensed Pharmacy

  • HIPAA Compliant

  • LegitScript Certified

Overview

Mechanism of Action

Activates glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, increasing insulin secretion, decreasing glucagon secretion, increasing insulin sensitivity, and delaying gastric emptying.

Prefilled Autoinjector Pen

Delivers a precise dose subcutaneously once weekly. Inject in the abdomen, thigh, or upper arm and rotate sites weekly.

Information presented here is for educational purposes only and not intended to replace or substitute guidance from a healthcare provider.

Benefits

Superior Glycemic Control

Dual receptor activation achieves greater HbA1c reduction than GLP-1 monotherapy alone, based on SURPASS trial data.

Meaningful Weight Loss

Clinical trial patients achieved body weight reductions that exceeded prior GLP-1 benchmarks, including losses greater than 20% in some cohorts.

GIP Receptor Action

Activates GIP receptors to enhance insulin secretion and promote fat metabolism beyond what GLP-1 stimulation achieves independently.

GLP-1 Receptor Action

Suppresses glucagon, slows gastric emptying, and reduces appetite through the well-established GLP-1 pathway for blood sugar and weight management.

Once-Weekly Convenience

A single subcutaneous injection per week via prefilled autoinjector pen maintains stable plasma tirzepatide levels for consistent glycemic control.

Simple. Medical. Personalized.

Medical intake

Answer a few online questions about your health history, lifestyle, & goals. No clinic visits required.

Provider evaluation

A licensed medical professional reviews your intake to determine the safest, personalized treatment.

Personalized plan

Custom treatment plan built around your unique health needs, goals, medical history, & biology.

Ongoing support

Stay connected with your care team for follow-ups, adjustments, & expert answers 100% online.

What Patients Are Experiencing

"After reviewing the SURPASS trial data, I started MOUNJARO. My HbA1c and weight loss exceeded anything I had seen with prior medications."

— William S.*

"My A1C went from 9.1 to 6.4 in five months. My endocrinologist was genuinely surprised at how quickly I responded."

— Linda F.*

"The prefilled pen is the easiest thing I have ever used. One click per week and my metabolic markers have never been stronger."

— George B.*

*Individual experiences may vary. Not all patients will have the same outcomes.

FAQs

Does MOUNJARO require a prescription?

Yes. MOUNJARO is an FDA-approved prescription medication. A telemedicine evaluation with a licensed provider is required before a prescription can be issued.

What are the possible side effects?

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal pain, typically most pronounced in the first weeks and improving as your dose is titrated. Pancreatitis has been reported — stop use and contact your provider immediately if you develop persistent, severe abdominal pain. Hypoglycemia risk increases when used with insulin or insulin secretagogues. Worsening of diabetic retinopathy has been reported. In animal studies, GIP/GLP-1 receptor agonists have been associated with thyroid C-cell tumors; contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.

Who Should Not Use MOUNJARO?

Contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2. Not for use during pregnancy. Use with caution in patients with a history of pancreatitis or diabetic retinopathy.

Are there any drug interactions?

Use with caution when combined with insulin or insulin secretagogues due to hypoglycemia risk. MOUNJARO may slow gastric emptying and affect timing of oral medication absorption. Disclose all current medications to your provider.

Is MOUNJARO safe if I have a pre-existing medical condition?

Use with caution in patients with a history of pancreatitis, significant renal impairment, or diabetic retinopathy. Serious hypersensitivity reactions require immediate discontinuation. Full medical review is required for all patients.

Start Your Journey

Ready for Clinically Proven Dual-Receptor Therapy?

Physician-supervised. MOUNJARO delivered to your door.

No clinic visits required.

  • Licensed Provider

  • Licensed Pharmacy

  • HIPAA Compliant

  • LegitScript Certified

The information and products provided on this website are for educational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All treatments require evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and products carry potential risks and side effects. Certain products may not be evaluated by the U.S. Food and Drug Administration (FDA) unless explicitly stated. Services are provided by licensed physicians and nurse practitioners in states where they are authorized to practice, including California, Florida, Nevada, and other participating states. This service is not intended for medical emergencies. If you are experiencing an emergency, call 911 or seek immediate medical care. We take reasonable measures to protect personal health information in accordance with applicable privacy laws, including HIPAA. By using this website or its services, you agree to our Terms of Service, Privacy Policy, and Telehealth Consent. You must be 18 years of age or older to use this service. We do not manufacture, handle, or ship medications.